14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 24 Apr 2024

Trading levels for CRBP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 41.26 9.44 %
R2 40.08 6.30 %
R1 39.34 4.36 %
Current price: 37.70
Support S1 36.98 -1.92 %
S2 36.24 -3.86 %
S3 35.06 -7.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.93 19.18 %
R2 40.32 6.95 %
R1 39.24 4.08 %
Current price 37.70
Support S1 34.60 -8.22%
S2 30.90 -18.04%
S3 29.49 -21.78%

CRBP Predictions History

2 years ago
Cristi Dumitru predicted that CRBP for 2021-12-06 is going $0.760 (-96.58%)

Rank:

2 years ago
siyoniko.281171 predicted that CRBP for 2021-12-06 is going

Rank:

2 years ago
JS predicted that CRBP for 2021-05-14 is going $1.31 (-21.56%)

2 years ago
bobbe.borisov.238064 predicted that CRBP for 2021-05-14 is going $1.49 (7.19%)

Rank:

2 years ago
JS predicted that CRBP for 2021-05-07 is going $1.47 (-10.91%)

2 years ago
SebastianRyszkiewicz predicted that CRBP for 2021-05-07 is going

Rank:

3 years ago
JS predicted that CRBP for 2021-03-01 is going $2.14 (-10.83%)

3 years ago
Dabn predicted that CRBP for 2021-03-01 is going

Rank:

3 years ago
JS predicted that CRBP for 2021-02-23 is going $2.67 (5.53%)

3 years ago
JavVidu predicted that CRBP for 2021-02-23 is going $3.00 (8.70%)

Rank:
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT